Nanoparticulate delivery of irinotecan active metabolite (SN38) in murine colorectal carcinoma through conjugation to poly (2-ethyl 2-oxazoline)-b-poly (L-glutamic acid) double hydrophilic copolymer
-
Add time:08/02/2019 Source:sciencedirect.com
SN-38 is the active metabolite of irinotecan, an FDA-approved chemotherapeutic agent indicated for colorectal carcinoma, which would not be clinically applicable due to its very poorly soluble and hydrolytic degradation properties. To overcome these limitations, it was proposed to conjugate SN38 to residing carboxylic acid residues in poly (2-ethyl 2-oxazoline) block poly (L-glutamic acid), inducing nano-assembly in aqueous medium. Following a series of reactions including poly (2-ethyl oxazoline) macro-initiated ring opening polymerization of N-carboxyanhydride, deprotection of benzyl group and chemical conjugation of SN38 via biodegradable ester linkage, the as-synthesized product was characterized by dynamic light scattering, ζ potential and transmission electron microscopy. The resulting particles presented about 90% loading efficiency with a mean size of 90 nm. Upon incubation with colorectal carcinoma CT26 cell line, higher association of SN-38 fluorescence and significantly more specific cytotoxicity was noticed for the SN38 conjugated particles than free drug. Therapeutic applicability of the as-synthesized product was evaluated in CT26 allograft tumor model in BALB/c mice, showing superior efficiency of the SN38 conjugated particles particularly in tumors with sizes larger than 200 mm3 than parent irinotecan and reduced mortality rate by 2.5 times. Conclusively, the poly (2-ethyl 2-oxazoline) decorated nano-conjugates of poly (L-glutamic acid) and SN38 can be regarded as a novel and potentially efficient drug delivery system for advanced colorectal carcinoma.
We also recommend Trading Suppliers and Manufacturers of 2-Ethyl-2-oxazoline (cas 10431-98-8). Pls Click Website Link as below: cas 10431-98-8 suppliers
Prev:Effect of crosslinking stage on photocrosslinking of benzophenone functionalized poly(2-Ethyl-2-oxazoline (cas 10431-98-8)) nanofibers obtained by aqueous electrospinning
Next:Aqueous electrospinning of poly(2-Ethyl-2-oxazoline (cas 10431-98-8)): Mapping the parameter space) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Poly(2-Ethyl-2-oxazoline (cas 10431-98-8)) as an Alternative to Poly(Vinylpyrrolidone) in Solid Dispersions for Solubility and Dissolution Rate Enhancement of Drugs08/08/2019
- Plasma polymerized 2-Ethyl-2-oxazoline (cas 10431-98-8): Chemical characterization and study of the reactivity towards different chemical groups08/07/2019
- Development of gold-core silica shell nanospheres coated with poly-2-ethyl-oxazoline and β-cyclodextrin aimed for cancer therapy08/06/2019
- Novel self-assembled micelles of amphiphilic poly(2-Ethyl-2-oxazoline (cas 10431-98-8)) -poly(L-lactide) diblock copolymers for sustained drug delivery08/05/2019
- Interpolymer complexes of carbopol® 971 and poly(2-Ethyl-2-oxazoline (cas 10431-98-8)): Physicochemical studies of complexation and formulations for oral drug delivery08/04/2019
- Aqueous electrospinning of poly(2-Ethyl-2-oxazoline (cas 10431-98-8)): Mapping the parameter space08/03/2019
- Effect of crosslinking stage on photocrosslinking of benzophenone functionalized poly(2-Ethyl-2-oxazoline (cas 10431-98-8)) nanofibers obtained by aqueous electrospinning08/01/2019
- Chitosan/poly(2-Ethyl-2-oxazoline (cas 10431-98-8)) films for ocular drug delivery: Formulation, miscibility, in vitro and in vivo studies07/31/2019


